Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Annapolis Ledger.
Press releases published on May 28, 2025

EPS Industry Alliance Sees Surge in Recycling Locations Across North America
EPS-IA adds over 150 new locations to interactive recycling map CROFTON , MD, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- EPS Industry Alliance (EPS-IA), the North American trade association representing the expanded polystyrene (EPS) industry, …

Baltimore City Board of School Commissioners Chooses Firm for CEO Search
School district selects Alma Advisory Group to assist in hiring of new CEO BALTIMORE, MD, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Baltimore City Public Schools (City Schools) is pleased to announce that Alma Advisory Group has been chosen to …

Chesapeake Bay Motoring Festival is June 7-8 on Kent Island
CHESTER, MD, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Car enthusiasts and maritime aficionados can get their motors running for a weekend of elegance and motoring excellence at the 9th annual Chesapeake Bay Motoring Festival, set for Saturday …

WILL Interactive Wins TELLY Awards for Groundbreaking Immersive Training
POTOMAC, MD, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- WILL Interactive has earned two honors in the 46th Annual Telly Awards, which recognize excellence in video and television across all screens. The awards celebrate WILL’s continued innovation …

Supernus Announces Paragraph IV ANDA Filings for Qelbree®
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that …

Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
SILVER SPRING, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced the publication of a peer-reviewed article describing the first validated method …